Abstract
Since 1987, the development of boron neutron capture therapy has been actively pursued at the Petten research site1, where the High Flux Reactor (HFR), a multi-purpose research reactor, has been the focal point of the European Collaboration group’s prime goal, namely: demonstration of BNCT in Europe2. The group has two goals: i) the initiation of clinical trials of glioma patients at the earliest possible date at the HFR, and ii) the creation of conditions for the treatment of other tumours at other centres in Europe. It was decided at an early stage that, amongst other reasons, due to the fact that the tissue at greatest risk is the healthy brain and from the experience gained in Japan, the treatment of glioma by BNCT should be performed with the boron carrier, borocaptate sodium, ie. BSH.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
R.L.Moss, F.Stecher-Rasmussen, R.Huiskamp, L.Dewit and B.Mijnheer, “The Petten BNCT project”, in: “Progress in Neutron Capture Therapy for Cancer”, Ed. B.J.Allen et al, Plenum Press, Proc. Fourth Int. Symposium Neutron Capture Therapy for Cancer, Sydney, 1990.
D.Gabel, “Approach to boron neutron capture therapy in Europe: Goals of a European collaboration on boron neutron capture therapy”, Proc. 2nd. Eur. Particle Accelerator Conf., Nice, 1990
R.L.Moss, F.Stecher-Rasmussen, K.Ravensberg, G.Constantine, and P.R.D.Watkins, “Design, construction and installation of an epithermal neutron beam for BNCT at the high flux reactor Petten”, in: “Progress in Neutron Capture Therapy for Cancer”, Ed. B.J.Allen et al, Plenum Press, Proc. Fourth Int. Symposium Neutron Capture Therapy for Cancer, Sydney, 1990.
R.L.Moss, “Review of reactor-based neutron beam development for BNCT applications”, in: “Advances in Neutron Capture Therapy”, Ed. A.H.Soloway, R.F.Barth and D.E.Carpenter, Plenum Press, Proc. Fifth Int. Symposium Neutron Capture Therapy for Cancer, Ohio, 1992.
P.R.D.Watkins et al, “Nuclear characterisation of the HFR Petten BNCT facility”, idem.
J.Crawford, S.Teichmann and F.Stecher-Rasmussen, “A direct comparison of neutron energy spectra at high and low rates”, these proceedings.
M.G.Carolan et al, “Validation of Monte Carlo dose planning calculations by epithermal beam dose distribution measurements in phantoms”, these proceedings.
C.P.J.Raaijmakers, M.W.Konijnenberg and B.J.Mijnheer, “Clinical dosimetry in an epithermal neutron beam”, these proceedings.
R.L.Moss, A.Siefert, P.R.D.Watkins, G.Constantine, F.Stecher-Rasmussen and K.Philipp, “Dosimetric Characterisation, Treatment Planning and Canine Tissue Tolerance Studies at the Petten BNCT Facility”, in: Topics in Dosimetry and Treatment Planning for Neutron Capture Therâpy“, Advanced Medical Publishing, 1994.
R.Huiskamp, A.C.Begg, V.G.A.Gregoire, R.Verrijk, D.Gabel, A.Siefert and R.L.Moss, “Radiobiology Studies at Petten: Status on cell culture, mice and dog experiments”, in: “Progress in Neutron Capture Therapy for Cancer”, Ed. B.J.Allen et al, Plenum Press, Proc. Fourth Int. Symposium Neutron Capture Therapy for Cancer, Sydney, 1990.
K.Philipp, R.Huiskamp, H.Philippo, J.Casado and R.L.Moss, “Normal tissue tolerance in a large animal model of boron neutron capture irradiation with borocaptate sodium (BSH)”, these proceedings.
F.J.Wheeler and D.W.Nigg, “Three-dimensional radiation dose distribution analysis for boron neutron capture therapy”, Nucl.Sci.Eng., 1992: 110: 16–31.
D.Haritz, B.Oterson, F.Grochulla, M.Bergmann, R.Huiskamp, D.Preusse and D.Gabel, “Pharmacokinetics and biodistribution in patients with malignant glioma and administration of N-acetylcysteine (N-AC) prior to Borocaptate Sodium (BSH), these proceedings.
G.Stragliotto and H.Fankhauser, “Biodistribution and pharmacokinetics of boron-sulfhydryl for boron neutron capture therapy in patients with intercranial tumors.”, Neurosurgery, 1995, 36: 285–293
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Moss, R.L. (1996). Status of the BNCT Project at the HFR Petten. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_40
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9567-7_40
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9569-1
Online ISBN: 978-1-4757-9567-7
eBook Packages: Springer Book Archive